The Oncology Institute, Inc. TOI Specialty pharmacy — Direct Operating Costs

Similar metrics at other companies

BTSGPharmacy Solutions — Other Direct Costs

$197.78M+9.5%

BGSSpecialty — Operating Expenses

$104.66M+3.8%

SCLSpecialty Products — Operating Expenses

$905K+0.9%

PRGOSpecialty Care — Total Operating Expenses

$58.9M-21.4%

CLMBDistribution — Direct Operating Costs

$12.84M+35.7%

AMRXSpecialty — Cost of goods sold

$43.02M-19.0%

Questions, answered.

What is The Oncology Institute, Inc.'s specialty pharmacy — direct operating costs?

The Oncology Institute, Inc. (TOI) reported specialty pharmacy — direct operating costs of $55.14M in Q4 2025.

How has The Oncology Institute, Inc.'s specialty pharmacy — direct operating costs changed year-over-year?

The Oncology Institute, Inc.'s specialty pharmacy — direct operating costs increased by 45.8% year-over-year, from $37.81M to $55.14M.

What does specialty pharmacy — direct operating costs mean?

This encompasses the immediate, variable expenses directly attributable to the fulfillment and delivery of services within the specialty pharmacy segment, such as drug acquisition costs and direct labor. It is a primary indicator of the segment's variable cost structure and gross margin performance. Investors use this to evaluate the segment's operational efficiency and its ability to manage supply chain expenses.